Back

Choose your region

Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
5601 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 70
5602 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 51
5603 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 53
5604 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 68
5605 Apheresis Allogeneic Myelodysplastic Syndrome In Fanconi Anemia Hematology 2017 Standard Therapy Poland 23
5606 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Of Blasts Hematology 2017 Standard Therapy Germany 62
5607 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 63
5608 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 63
5609 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 66
5610 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 62
5611 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 55
5612 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 62
5613 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 62
5614 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 72
5615 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Germany 70
5616 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2017 Standard Therapy Poland 47
5617 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 44
5618 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 56
5619 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 57
5620 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 38
5621 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2017 Standard Therapy Poland 7
5622 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2017 Standard Therapy Germany 37
5623 Apheresis Allogeneic Niemann–Pick Disease Hematology 2017 Standard Therapy Poland 2
5624 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 36
5625 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 58
5626 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 53
5627 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 1
5628 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 55
5629 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 63
5630 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 56
5631 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 47
5632 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 57
5633 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 65
5634 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 58
5635 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 42
5636 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 36
5637 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 63
5638 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 68
5639 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 52
5640 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 53
5641 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 56
5642 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 65
5643 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 55
5644 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 69
5645 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 69
5646 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Germany 72
5647 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Germany 51
5648 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Germany 57
5649 Apheresis Autologous Non-Hodgkin-Lymphoma-Relapse Hematology 2017 Standard Therapy Germany 52
5650 Apheresis Allogeneic Osteopetrosis Metabolic 2017 Standard Therapy Poland 3
5651 Apheresis Allogeneic Other Malignancy Hematology 2017 Standard Therapy Poland 59
5652 Apheresis Allogeneic Other Myelofibrosis Hematology 2017 Standard Therapy Poland 71
5653 Apheresis Allogeneic Post–Polycythemia Vera Myelofibrosis Hematology 2017 Standard Therapy Germany 61
5654 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2017 Standard Therapy Germany 51
5655 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2017 Standard Therapy Germany 66
5656 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2017 Standard Therapy Germany 50
5657 Apheresis Allogeneic Primary Immunodeficiency Hematology 2017 Standard Therapy Poland 4
5658 Apheresis Allogeneic Primary Immunodeficiency Hematology 2017 Standard Therapy Poland 2
5659 Apheresis Allogeneic Primary Myelofibrosis Hematology 2017 Standard Therapy Poland 29
5660 Apheresis Allogeneic Primary Myelofibrosis Hematology 2017 Standard Therapy Poland 32
5661 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2017 Standard Therapy Poland 38
5662 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2017 Standard Therapy Poland 63
5663 Apheresis Allogeneic Richter's Transformation At Chronic Lymphocytic Leukemia Hematology 2017 Standard Therapy Germany 60
5664 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2017 Standard Therapy Poland 24
5665 Apheresis Allogeneic Secondary Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 61
5666 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2017 Standard Therapy Poland 14
5667 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2017 Standard Therapy Poland 27
5668 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2017 Standard Therapy Poland 32
5669 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2017 Standard Therapy Poland 16
5670 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2017 Standard Therapy Poland 30
5671 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2017 Standard Therapy Poland 7
5672 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2017 Standard Therapy Poland 25
5673 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2017 Standard Therapy Poland 28
5674 Apheresis Allogeneic T-Cell Lymphoblastic Leukemia Hematology 2017 Standard Therapy Germany 24
5675 Apheresis Allogeneic T-Cell Lymphoblastic Lymphoma Hematology 2017 Standard Therapy Germany 19
5676 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Germany 56
5677 Apheresis Autologous T-Cell-Lymphoma Hematology 2017 Standard Therapy Germany 63
5678 Apheresis Allogeneic Β – Thalassemia Major Hematology 2017 Standard Therapy Poland 4
5679 Cord Tissue Allogeneic – Unrelated Limb-Girdle Muscular Dystrophy Neurology 2016 Experimental Therapy Poland 22
5680 Cord Tissue Allogeneic – Unrelated Limb-Girdle Muscular Dystrophy Neurology 2016 Experimental Therapy Poland 32,3
5681 Cord Tissue Allogeneic – Unrelated Limb-Girdle Muscular Dystrophy Neurology 2016 Experimental Therapy Poland 44,7
5682 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2016 Experimental Therapy Poland 14
5683 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2016 Experimental Therapy Poland 6
5684 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2016 Experimental Therapy Poland 60,5
5685 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2016 Experimental Therapy Poland 3,11
5686 Cord Tissue Allogeneic – Unrelated Adrenoleukodystrophy Neurology 2016 Experimental Therapy Poland 11,11
5687 Cord Tissue Allogeneic – Unrelated Adrenoleukodystrophy Neurology 2016 Experimental Therapy Poland 6,11
5688 Cord Tissue Allogeneic – Unrelated Adrenoleukodystrophy Neurology 2016 Experimental Therapy Poland 9,7
5689 Cord Tissue Allogeneic – Unrelated Adrenoleukodystrophy; Encephalopathy Neurology 2016 Experimental Therapy Poland 8,4
5690 Cord Tissue Allogeneic – Unrelated Age-Related Macular Degeneration Ophthalmology 2016 Experimental Therapy Poland 86,5
5691 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 44,5
5692 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 60,8
5693 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 32,2
5694 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 53,7
5695 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 59,4
5696 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 33,4
5697 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 37,4
5698 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 39,3
5699 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 63,2
5700 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2016 Experimental Therapy Poland 54,11